Sangamo Therapeutics
SGMO
#10419
Rank
ยฃ23.01 M
Marketcap
ยฃ0.05555
Share price
0.00%
Change (1 day)
-87.34%
Change (1 year)

Sangamo Therapeutics (SGMO) - Total assets

Total assets on the balance sheet as of March 2026 : ยฃ45.01 Million

According to Sangamo Therapeutics 's latest financial reports the company's total assets are ยฃ45.01 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Sangamo Therapeutics - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31ยฃ44.36 M-45.22%
2024-12-31ยฃ80.98 M-37.59%
2023-12-31ยฃ0.12 B-72.09%
2022-12-31ยฃ0.46 B-13.06%
2021-12-31ยฃ0.53 B-22.33%
2020-12-31ยฃ0.68 B41.63%
2019-12-31ยฃ0.48 B4.53%
2018-12-31ยฃ0.46 B119.22%
2017-12-31ยฃ0.21 B65.8%
2016-12-31ยฃ0.12 B-12.71%
2015-12-31ยฃ0.14 B-6.16%
2014-12-31ยฃ0.15 B82.96%
2013-12-31ยฃ85.38 M67.21%
2012-12-31ยฃ51.06 M-9.12%
2011-12-31ยฃ56.19 M37.69%
2010-12-31ยฃ40.81 M-24.47%
2009-12-31ยฃ54.03 M16.72%
2008-12-31ยฃ46.29 M9.62%
2007-12-31ยฃ42.23 M48.3%
2006-12-31ยฃ28.47 M0.25%
2005-12-31ยฃ28.4 M57.04%
2004-12-31ยฃ18.08 M-30.01%
2003-12-31ยฃ25.84 M-26.3%
2002-12-31ยฃ35.06 M-40.2%
2001-12-31ยฃ58.63 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
ยฃ150.81 B 334,918.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ69.44 B 154,163.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ22.13 B 49,067.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
ยฃ44.87 B 99,591.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ42.24 B 93,751.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ96.60 B 214,500.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ3.85 B 8,454.24%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ6.44 B 14,226.72%๐Ÿ‡บ๐Ÿ‡ธ USA